Latest HBcAg Stories
Three new studies presented today at the International Liver CongressTM 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB).
Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication.
â€¢ 96-week study in a population of nucleos(t)ide-naïve patients with chronic hepatitis B (CHB) infection â€¢ Data presented at the American Association for the Study of Liver Diseases congress
BOSTON, Nov. 1, 2010 /PRNewswire/ -- Researchers studied the treatment of pregnant women with hepatitis B virus (HBV) with Telbivudine in their second to third trimesters.
Hepatitis B virus (HBV) genotypes have distinct geographical distributions, and have been shown to differ with regard to clinical outcome and prognosis.
Hepatitis B virus (HBV) infection is a dynamic process with variable biochemical, virological and histological profiles at different stages of the infection, depending on host and viral factors.
Gilead Sciences, a biopharmaceutical company, has presented two-year data from two Phase III pivotal clinical trials, studies 102 and 103, evaluating the safety and efficacy of once-daily Viread among adult patients with chronic hepatitis B virus infection.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.